Measurement of radiation dose delivered to breast tissue during mantle field irradiation for Hodgkin's disease

Medical Dosimetry

Volumn 23, Issue 1, 1998, Pages 31-36

  Kowalski, Alex ^a   Smith, Susan ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Breast dose; Hodgkin's disease; Mantle fields; TLDs

Indexed keywords

ARTICLE; BREAST; CANCER RADIOTHERAPY; HODGKIN DISEASE; HUMAN; MANTLE FIELD RADIOTHERAPY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; THERMOLUMINESCENCE DOSIMETRY;

BREAST; FEMALE; HODGKIN DISEASE; HUMANS; MODELS, STRUCTURAL; RADIOTHERAPY; RADIOTHERAPY DOSAGE; THERMOLUMINESCENT DOSIMETRY;

EID: 0032029475     PISSN: 09583947     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0958-3947(97)00108-8     Document Type: Article

References (17)

1. Cox J.D. Moss' Radiation oncology rationale, techniques, results . 7th ed. 1994;804-826 Moss, New York.
2. Hoppe R.T., Glatstein E., Wasserman T.H. Hodgkin's disease. Perez C., Brady L. Principles and practice of radiation oncology. 2nd ed. 1992;Lippincott, New York.
3. Bhatia S., Robison L.L., Oberlin O., Greenberg M., Bunin G., Fossati-Bellani F., Meadows A.T. Breast cancer and other second neoplasms after childhood Hodgkin's disease. N. Engl. J. Med. 334:(12):1992;745-751.
4. Mauch P.M., Kalish L.A., Marcus K.C., Coleman C.N., Shulman L.N., Krill E., Come S., Silver B., Canellos G.P., Tarbell N.J. Second malignancies after treatment for laparotomy staged IA - IIIB Hodgkin's disease long-term analysis of risk factors and outcome . Blood. 87:(9):1996;3625-3632.
5. Tucker M.A., Coleman C.N., Cox R.S., Varghese A., Rosenberg S.A. Risk of second cancers after treatment for Hodgkin's disease. N. Engl. J. Med. 318:(2):1988;76-81.
6. Salloum E., Doria R., Schubert W., Zelterman D., Holford T., Roberts K.B., Farber L.R., Kiehl R.K., Cardinale J., Cooper D.L. Second solid tumors in patients with Hodgkin's disease cured after radiation or chemotherapy plus adjuvant low-dose radiation. J. Clin. Oncol. 14:(9):1996;2435-2443.
7. Yahalom J., Petrek J.A., Biddinger P.W., Kessler S., Dershaw D.D., McCormick B., Osborne M.P., Kinne D.A., Rosen P.P. Breast cancer in patients irradiated for Hodgkin's disease a clinical and pathologic analysis of 45 events in 37 patients . J. Clin. Oncol. 10:(11):1992;1662-1665.
8. Hancock S.L., Tucker M.A., Hoppe R.T. Breast cancer after treatment of Hodgkin's disease. J. Natl. Cancer Inst. 85:(1):1993;25-31.
9. Boice J.D. Jr, Preston D., Preston F.G., Monson R.R. Frequent chest X-ray fluoroscopy and breast cancer incidence among tuberculosis patients in Massachusetts. Radiat. Res. 125:(2):1991;214-222.
10. Land C.E. Studies of cancer and radiation dose among atomic bomb survivors The example of breast cancer . JAMA. 274:(5):1995;402-407.
11. Tokunaga M., Land C.E., Tokuoka S., Nishimori I., Soda M., Akiba S. Incidence of female breast cancer among atomic bomb survivors, 1950-1985. Radiat. Res. 138:(2):1994;209-223.
12. Smith L.M., Evans J.W., Mair M., Brown J.M. The frequency of translocations after treatment for Hodgkin's disease. Int. J. Rad. Oncol. Biol. Phys. 24:(4):1992;737-742.
13. Wazer D.E., Chu Q., Liu X.L., Gao Q., Safaii H., Band V. Loss of p53 protein during radiation transformation of primary human mammary epithelial cells. Mol. Cell. Biol. 14:(4):1994;2468-2478.
14. Janjan N.A., Zellmer D.L. Calculated risk of breast cancer following mantle irradiation determined by measured dose. Cancer Detec. Prev. 16:(5)(6):1992;273-282.
15. Kirby T.H., Hanson W.F., Gastorf R.J., Chu C.H., Shalek R.J. Mailable TLD system for photon and electron therapy beams. Int. J. Radiat. Oncol. Biol. Phys. 12:(2):1986;261-265.
16. Janjan N.A., Wilson J.F., Gillin M., Anderson T., Greenberg M., Schewe K., Cox J.D. Mammary carcinoma developing after radiotherapy and chemotherapy for Hodgkin's disease. Cancer. 61:1988;252-254.
17. Karasek K., Deutsch M. Lumpectomy and breast irradiation for breast cancer after radiotherapy for lymphoma. Am. J. Clin. Oncol. 19:(5):1995;451-454.